These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16691638)

  • 21. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
    Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
    Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.
    Schuster R; Max N; Mann B; Heufelder K; Thilo F; Gröne J; Rokos F; Buhr HJ; Thiel E; Keilholz U
    Int J Cancer; 2004 Jan; 108(2):219-27. PubMed ID: 14639606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.
    Yadegarazari R; Hassanzadeh T; Majlesi A; Keshvari A; Monsef Esfahani A; Tootoonchi A; Shabab N; Saidijam M
    Iran Biomed J; 2013; 17(1):15-21. PubMed ID: 23279830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
    Wong IH; Yeo W; Chan AT; Johnson PJ
    Int J Oncol; 2001 Mar; 18(3):633-8. PubMed ID: 11179498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
    Dandachi N; Balic M; Stanzer S; Halm M; Resel M; Hinterleitner TA; Samonigg H; Bauernhofer T
    J Mol Diagn; 2005 Nov; 7(5):631-7. PubMed ID: 16258162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined detection of CEA mRNA and CK 19 mRNA in peripheral blood cells of patients with lung cancer].
    Li XF; Hu Y; Zhang SZ; Zheng S
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):382-4. PubMed ID: 15312354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
    López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
    J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer.
    Auf FA; El-Eibdy GK; Mosaad YM; El-Ghannam DM; El-Masry EE
    J Oncol Pharm Pract; 2011 Sep; 17(3):160-7. PubMed ID: 20395351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR.
    Šamija I; Lukač J; Mubrin MK; Kirac I; Kovačević D; Kusić Z
    Int J Biol Markers; 2013 Jun; 28(2):174-81. PubMed ID: 23558939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
    Tamura N; Iinuma H; Takada T
    Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical Significance of CK20, CK19, CEA mRNAs in Peripheral Blood from Lung Cancer Patients.].
    Guo Y; Wang J; Huang P
    Zhongguo Fei Ai Za Zhi; 2009 Sep; 12(9):1013-7. PubMed ID: 20719202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].
    Wang JH; Zhang SC; Liu ZD; Chen XY; Li CY; Han Y; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):773-6. PubMed ID: 16324274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen.
    Kodera Y; Nakanishi H; Ito S; Yamamura Y; Fujiwara M; Koike M; Hibi K; Ito K; Tatematsu M; Nakao A
    Gastric Cancer; 2005; 8(3):142-8. PubMed ID: 16086116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance].
    Na GW; Li J; He KJ; Li HH; Zhao XN; Li XW; Mi HN
    Ai Zheng; 2004 Nov; 23(11):1350-3. PubMed ID: 15522189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HERG1 gene expression as a specific tumor marker in colorectal tissues.
    Dolderer JH; Schuldes H; Bockhorn H; Altmannsberger M; Lambers C; von Zabern D; Jonas D; Schwegler H; Linke R; Schröder UH
    Eur J Surg Oncol; 2010 Jan; 36(1):72-7. PubMed ID: 19577877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.